Why the study?
Do antiarrhythmic agents alter the pacing rate required to produce alternating Wenckebach periods in patients undergoing electrophysiological study?
Do antiarrhythmic agents alter the pacing rate required to produce alternating Wenckebach periods in patients undergoing electrophysiological study?
The pacing rate required to produce alternating Wenckebach periodicity is a sensitive electrophysiological variable for evaluating the effects of antiarrhythmic drugs on atrioventricular nodal conduction.
Answers are grounded in this paper and cite their sources.
May indicate drug-specific effects on AV nodal properties in alternating Wenckebach; leaves open confirmation in controlled electrophysiological studies.
Electrophysiological variables were studied in 19 patients before and after one of three commonly used antiarrhythmic agents. The pacing rate at which alternating Wenckebach periods appeared in eight patients was significantly reduced by intravenous digoxin (0.01 mg/kg body weight). The atrioventricular nodal conduction time (A-H interval) and Wenckebach point were not significantly altered by digoxin. Intravenous propranolol (0.1 mg/kg body weight) in four patients did not affect the A-H interval, but it reduced the pacing rates at which the Wenckebach point and alternating Wenckebach periods occurred. Intravenous disopyramide (2 mg/kg body weight) significantly increased the pacing rate required to produce alternating Wenckebach periods but did not significantly alter the other indicators of atrioventricular conduction in seven patients. It is concluded that the pacing rate required to produce alternating Wenckebach periodicity may be a useful and sensitive variable in the evaluation of the effect of antiarrhythmic agents on atrioventricular nodal conduction.
No takes yet. Share an insight, caveat, or question.
Lévy et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: